Endo shareholders will get $80 million in cash and own 49.9% of the combined company, while Mallinckrodt shareholders will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback